-
NMPA Announcement on Issuing the Requirements for Change Items and Application Dossiers of Marketed Biological Products
2021-06-18
The NMPA has organized to formulate the Requirements for Change Items and Application Dossiers of Marketed Biological Products, which has been issued and implemented on June 17.
-
NMPA Announcement on Issuance and Implementation of the Measures for the Administration of Cosmetics Labels
2021-06-03
In order to strengthen the supervision and administration of cosmetics labels, standardize the use of cosmetics labels and protect the legitimate rights and interests of consumers, according to the Regulations for the Supervision and Administration of Cosmetics, NMPA has drafted the Measures for the Administration of Cosmetics Labels.
-
NMPA Announcement on Updating the Catalogue of Raw Materials Banned for Cosmetics
2021-05-28
NMPA has organized the revisions to the Banned Components for Cosmetics (Table 1) and Banned Plant (Animal) Components for Cosmetics (Table 2) in the Technical Specification for the Safety of Cosmetics (Edition 2015) and formed the Catalogue of Raw Materials Banned for Cosmetics and Catalogue of Plant (Animal) Raw Materials Banned for Cosmetics.
-
NMPA Announcement on Approving the Registration of 139 Medical Devices
2021-05-24
In April 2021, NMPA approved the registration of a total of 139 medical devices. Among them, there are 100 domestic Class III medical devices, 19 imported Class III medical devices, 19 imported Class II medical devices, and 1 medical device from Hong Kong, Macao and Taiwan.
-
NMPA Announcement on Issuing the Good Pharmacovigilance Practice
2021-05-13
NMPA has organized to formulate the Good Pharmacovigilance Practice to standardize and guide drug marketing authorization holders and drug registration applicants to conduct pharmacovigilance activities.
-
NMPA Announcement on the Applicability of ICH Guidelines M9: Biopharmaceutics Classification System-based Biowaivers and Q&A Document thereof and Q5D Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products
2021-05-07
In order to promote the technical standards of drug registration in line with international standards, upon study, NMPA decided to apply the ICH Guidelines M9 Biopharmaceutics Classification System-based Biowaivers and Q&A document thereof and Q5D Derivation and Characterisation of Cell Substrates Used for Production of Biotechnological/Biological Products.